Ibogaine News · Saturday, October 10, 2026

Black Betty Mustang auction to benefit ibogaine research

Proceeds from the auction will support Americans for Ibogaine's efforts to mainstream ibogaine treatment.

Black Betty Mustang to be Auctioned for Ibogaine Research

A classic 1968 Mustang, affectionately known as Black Betty, is set to be auctioned on October 24, 2026, at the Mecum auction in Fort Worth, Texas. The proceeds from this auction will benefit Americans for Ibogaine (AFI), a nonprofit organization dedicated to promoting the medical use of ibogaine, a psychoactive substance studied for its potential in treating addiction and mental health conditions.

Auction Details

Black Betty will be auctioned at Dickies Arena in Fort Worth as part of the Mecum Dallas/Fort Worth event. The car will be sold with no reserve and no fees, ensuring that 100% of the proceeds go directly to AFI. Interested bidders can participate in person or online via Mecum's Bid From Anywhere platform, and the event will be streamed live on Mecum.com and ESPN+.

Americans for Ibogaine's Mission

Americans for Ibogaine, co-founded by former Texas Governor Rick Perry and W. Bryan Hubbard, aims to advance responsible medical access to ibogaine. The organization focuses on legislative efforts, federal rescheduling pathways, and international research partnerships. AFI was instrumental in the passage of Texas Senate Bill 2308, which established the largest state-funded ibogaine research initiative in the United States.

Why It Matters

The auction of Black Betty represents a unique fundraising effort for AFI, highlighting the organization's innovative approach to supporting ibogaine research. With high-profile endorsements and media attention, including appearances on popular podcasts and documentaries, AFI is working to bring ibogaine into the mainstream as a treatment option for addiction and mental health issues.

Black Betty's auction is a significant step in raising awareness and funds for ibogaine research, potentially paving the way for broader acceptance and use of this promising treatment.

Sources

Reporting based on finance.yahoo.com. Read the original in the Sources section above.

Get the newsletter

Ibogaine news, in your inbox.

Occasional dispatches. No spam.